Oneview boosts cash reserves and advances AI care platform amid U.S. growth push

Oneview Healthcare Chess Depository Interests repr 1 ( (AU:ONE) ) has issued an announcement.

Oneview Healthcare reported a cash balance of €10.3 million at 31 March 2026, boosted by the first tranche of a two-part CHESS Depositary Interests placement that raised A$19 million in gross proceeds. The second tranche, expected to add A$7 million, is subject to shareholder approval later in 2026, while a subsequent security purchase plan contributed a further A$0.3 million, and underlying quarterly cash outflow narrowed to €1.1 million due to cost reductions from a 2025 restructuring.

The company is advancing sales opportunities through Baxter and direct channels, including negotiations with one of the ten largest U.S. health systems, and reported strong lead generation from major industry conferences. It is also expanding deployments with existing customers and progressing development of its AI-enabled care assistant Ovie and a redesigned patient interface, with pilot projects planned in 2026 to support future commercial rollout and platform scalability.

The most recent analyst rating on (AU:ONE) stock is a Buy with a A$0.45 price target. To see the full list of analyst forecasts on Oneview Healthcare Chess Depository Interests repr 1 stock, see the AU:ONE Stock Forecast page.

More about Oneview Healthcare Chess Depository Interests repr 1

Oneview Healthcare PLC is a global healthcare technology company that provides bedside technology and digitally integrated care solutions for hospitals and health systems. Its platform focuses on virtualising care, enhancing patient self-service and in-room communication, and supporting providers facing workforce challenges, with a growing presence in major U.S. health systems via partners such as Baxter.

YTD Price Performance: -56.96%

Average Trading Volume: 195,450

Technical Sentiment Signal: Sell

Current Market Cap: A$130.4M

Learn more about ONE stock on TipRanks’ Stock Analysis page.